Travere Therapeutics Stock (NASDAQ: TVTX) stock price, news, charts, stock research, profile.
You can purchase shares of Travere Therapeutics (NASDAQ:TVTX) through any online brokerage.
Other companies in Travere Therapeutics’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), Gyre Therapeutics (NASDAQ:GYRE), Cogent Biosciences (NASDAQ:COGT), Immatics (NASDAQ:IMTX) and Arcutis Biotherapeutics (NASDAQ:ARQT).
Travere Therapeutics has a consensus price target of $20.88.
The stock price for Travere Therapeutics (NASDAQ: TVTX) is $13.99 last updated October 1, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Travere Therapeutics.
Travere Therapeutics’s Q3 earnings are confirmed for Tuesday, November 5, 2024.
There is no upcoming split for Travere Therapeutics.
Travere Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.